Biggest News Aggregation in the World
📰 Tatra News

Page 28 - Tatra News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Tatra. Real-time updates on events, politics, business and more.

Insider Selling: Atara Biotherapeutics, Inc. (NASDAQ:ATRA) CFO Sells $16,152.72 in Stock

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) CFO Eric J. Hyllengren sold 7,918 shares of the stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $2.04, for a total transaction of $16,152.72. Following the sale, the chief financial officer now directly owns 226,142 shares in the company, […]
Ericj Hyllengren Ef Hutton Acquisition Co Wasatch Advisors Inc Baupost Group Atara Biotherapeutics Inc Goldman Sachs Group Inc

Eric J. Hyllengren Sells 7,918 Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Stock

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) CFO Eric J. Hyllengren sold 7,918 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $2.04, for a total transaction of $16,152.72. Following the sale, the chief financial officer now directly owns 226,142 shares […]
Ericj Hyllengren Envestnet Asset Management Inc Ef Hutton Acquisition Co Metlife Investment Management Atara Biotherapeutics Company Profile Atara Biotherapeutics Inc

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) EVP Amar Murugan Sells 8,389 Shares of Stock

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) EVP Amar Murugan sold 8,389 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $2.04, for a total transaction of $17,113.56. Following the sale, the executive vice president now owns 270,945 shares of the […]
Amar Murugan Caxton Associates Hennion Walsh Asset Management Inc Allspring Global Investments Holdings Atara Biotherapeutics Company Profile Lazard Asset Management

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of "Hold" by Analysts

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has been given a consensus rating of “Hold” by the nine analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average […]
Hong Kong Pascal Touchon Us Bancorp Securities Exchange Commission Nisa Investment Advisors Hong Kong Ltd
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science